飞利浦与可孚医疗达成战略合作，将高品质家庭健康监测设备引入中国

Core Viewpoint - The strategic partnership between Kefu Medical and Royal Philips aims to enhance the availability of high-quality home health monitoring devices in Chinese households through deep collaboration on technology and product development [1][3]. Group 1: Partnership Details - Kefu Medical will receive brand authorization from Royal Philips for various home health monitoring devices in China, including blood glucose meters, blood pressure monitors, continuous glucose monitoring devices, thermometers, pulse oximeters, pulmonary function testers, and scales [3]. - The collaboration will focus on joint technology research and development, local adaptation, and iterative upgrades, with Kefu Medical responsible for production, brand operation, channel layout, and service system construction in China [3][4]. Group 2: Company Profiles - Kefu Medical is one of China's largest home medical device companies, with over 20 years in the industry and a comprehensive supply chain covering R&D, production, distribution, e-commerce, and logistics [4]. - Royal Philips is a global leader in health technology, committed to improving health and well-being through innovation and providing personal health solutions [3][4]. Group 3: Market Context - The partnership aligns with China's national strategy to promote health, transitioning from a disease-centered approach to a health-centered one, as the demand for daily health monitoring devices continues to grow [4][5]. - The collaboration is expected to set new industry standards in technology, product innovation, and service quality, facilitating the faster and broader entry of advanced medical devices into Chinese households [5]. Group 4: Future Plans - The first batch of Philips smart monitoring medical devices is in the preparation stage for market launch, aiming to provide innovative and forward-looking product solutions to consumers [5]. - The products will leverage a strengthened online channel layout and a diverse distribution network, including retail systems, regional distributors, and chain pharmacies, to rapidly expand market coverage [5].